ArticleFrontiers in oncology2022

Case report: Kidney perivascular epithelioid cell tumor treated with anti-VEGFR tyrosine kinase inhibitor and MTOR inhibitor.

Ninggang Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.